Spyre Therapeutics, Inc.

Tower Research Capital LLC (TRC) SYRE

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

22,749

Value ($000)

Weight

0.0%

2019 Q4 - 2023 Q2 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	10	0.0%	22,749	6/30/2023
2023 Q1	5/9/2023	11	0.0%	37,381	3/31/2023
2022 Q4	2/10/2023	8	0.0%	17,844	12/31/2022
2022 Q3	11/10/2022	14	0.0%	26,886	9/30/2022
2022 Q2	8/15/2022	8	0.0%	15,689	6/30/2022
2022 Q1	5/12/2022	51	0.0%	22,079	3/31/2022
2021 Q4	2/14/2022	24	0.0%	4,952	12/31/2021
2021 Q3	11/15/2021	26	0.0%	3,250	9/30/2021
2021 Q2	8/16/2021	21	0.0%	3,021	6/30/2021
2021 Q1	5/17/2021	21	0.0%	2,649	3/31/2021
2020 Q4	2/16/2021	67	0.0%	8,502	12/31/2020
2020 Q3	11/16/2020	254	0.0%	35,775	9/30/2020
2020 Q2	8/13/2020	98	0.0%	10,606	6/30/2020
2019 Q4	2/7/2020	56	0.0%	7,312	12/31/2019